Indeed, additional promising drugs with multitarget activity (including ... treatment suggests that additional mechanisms of resistance to EGFR inhibitors may have a key role in regulating tumor ...

Current treatments, including tyrosine kinase inhibitors (TKIs) that target EGFR, are less effective against non-canonical mutations, leading to poor outcomes and drug resistance. New methods like ...

Recent research led by UTHealth Houston scientists has uncovered two genes associated with variants linked to epilepsy, which ...

The main clinical drug from its pipeline would be the use of ENV-105, which is a CD105 inhibitor, being developed to target patients with castrate-resistant prostate cancer [CRPC] and EGFR mutant ...

The firm also announced that it was divesting most of its equity interest in Shanghai Hutchison Pharmaceuticals to invest in its own pipeline.

For decades, treating lung cancer has been like trying to hit a moving target in the dark. Just when doctors think they've found an effective treatment, the cancer adapts and escapes. Now, a team of ...

What is the luckiest slot machine to Overcoming the drug resistance of EGFR-mutated non-small cell lung cancer: Clinical ...

Hutchmed China announced a number of advancements on Thursday, including a regulatory milestone for its lung cancer treatment ...

BitStarz 30 free splns Eli Lilly Biopharmaceuticals' third-generation EGFR-TKI "Afatinib" is listed Using multiple antibiotics in patients with b ...